Back
Corporate News
Natco Pharma’s board approved a Rs 12.8 billion rights issue for eligible shareholders
25-Sep-2026, 12:27
Natco Pharma Limited announced that its board of directors approved a rights issue of 1,70,58,082 equity shares at a price of Rs 750 per share, totaling Rs 12,79,35,61,500, to eligible shareholders as of the record date of October 1, 2026, with a rights entitlement ratio of 2 shares for every 21 shares held. The rights issue period will run from October 12, 2026, to October 22, 2026, and the company's outstanding equity shares will increase from 17,91,09,870 to 19,61,67,952 following full subscription.